Form D · Biotechnology
Adaptive Phage Therapeutics, Inc.
Gaithersburg, MD · CIK 0001701259
Offering snapshot reported Jun 9, 2023 · SEC filing
- Reported sold
- $12M Offering amount: $30M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 9, 2023 | Initial | $11,999,999 | No comparison | 4 | SEC filing |
| May 20, 2021 | Initial | $23,262,000 | No comparison | 59 | SEC filing |
| Aug 27, 2020 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Aug 24, 2020 | Initial | $3,350,000 | No comparison | 18 | SEC filing |
| Jun 22, 2020 | Initial | $2,825,000 | No comparison | 12 | SEC filing |
| Nov 27, 2019 | Amendment | $6,994,388 | $4,644,388vs Jun 5, 2018 | 40 | SEC filing |
| Jun 5, 2018 | Initial | $2,350,000 | No comparison | 8 | SEC filing |
| Apr 14, 2017 | Initial | $765,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483867
Source: Form D, filed Jun 9, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Subhendu Basu | Executive |
| Jesse Goodman | Director |
| Ian Hardy | Director |
| Martin Heidecker | Director |
| Jana Jensen | Director |
| Jonathan Leff | Director |
| Evan Loh | Director |
| Raymond L. Martz | Director |
| Gregory L. Merril | Director, Executive, Promoter |
| Carl R. Merril | Director |
| William Mutryn | Director |
| Michael Orndorff | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
708 Quince Orchard Road
Gaithersburg, MD, 20878
Gaithersburg, MD, 20878